OpenAlex
PricingAboutJobs
Log inGet started
Work

MDS-1271: Comparative Outcomes With Luspatercept Versus Erythropoiesis-Stimulating Agents in Lower-Risk Myelodysplastic Syndromes: A Propensity Score-Matched Retrospective Cohort Study

HTML

Year: 2026
Type: conference-abstract
Source: Clinical Lymphoma Myeloma & Leukemia
DOI: 10.1016/s2152-2650(26)02276-7
Authors: Shankar Biswas, Kumar Anmol, Emmanuel Kusi-Appiah, Dac Cuong Nguyen, Dhiraj Kumar Das, Yashasvi Srivastava, Archit Srivastava, Kofi Boakye Opoku
Institutions: Ivano-Frankivsk National Medical University, Reading Hospital, Rostov State Medical University, Universal College of Medical Sciences, Boston Medical Center, Hackensack Meridian Health, John F. Kennedy Medical Center
Language: English

Topic: Acute Myeloid Leukemia Research
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Keywords: luspatercept, erythropoiesis-stimulating agents, epoetin alfa, darbepoetin alfa, lower-risk myelodysplastic syndromes, anemia management, all-cause mortality, venous thromboembolism, heart failure, infection hospitalization, hypomethylating agents
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W7204707697
Cites:
Cited by:
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security